Vaishali Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	1,141	990.26	862.8	696.63	758.21	537.74
Other Revenue	0	0	-	-	-	-
Revenue	1,141	990.26	862.8	696.63	758.21	537.74
Revenue Growth (YoY)	15.04%	14.77%	23.85%	-8.12%	41.00%	-10.51%
Cost of Revenue	1,013	857.12	744.37	547	635.17	461.7
Gross Profit	127.44	133.14	118.43	149.63	123.04	76.04
Selling, General & Admin	33.27	30.29	28.11	26.1	22.13	19.39
Other Operating Expenses	55.98	46.52	28.03	29.75	32.06	11.97
Operating Expenses	150.32	137.11	112.13	60.89	58.75	53.83
Operating Income	-22.88	-3.97	6.3	88.74	64.29	22.21
Interest Expense	-16.84	-15.83	-17.37	-22.56	-24.89	-26.26
Interest & Investment Income	26.06	26.06	13.92	12.55	12.98	12.58
Currency Exchange Gain (Loss)	3.18	3.18	1.71	5.41	4.43	3.98
Other Non Operating Income (Expenses)	6.53	2.82	4.7	4.33	0.47	1.52
EBT Excluding Unusual Items	-3.76	12.26	9.26	88.46	57.28	14.05
Pretax Income	-3.76	12.26	9.26	88.46	57.28	14.05
Income Tax Expense	1.33	4.08	2.07	22.43	17.05	3.58
Net Income	-5.09	8.17	7.19	66.04	40.24	10.46
Net Income to Common	-5.09	8.17	7.19	66.04	40.24	10.46
Net Income Growth	-	13.70%	-89.11%	64.12%	284.58%	3091.34%
Shares Outstanding (Basic)	114	126	107	105	105	105
Shares Outstanding (Diluted)	114	126	107	112	105	105
Shares Change (YoY)	-17.49%	17.99%	-4.07%	5.95%	-	-
EPS (Basic)	-0.04	0.06	0.07	0.63	0.38	0.10
EPS (Diluted)	-0.05	0.06	0.07	0.59	0.38	0.10
EPS Growth	-	-10.54%	-88.65%	54.90%	284.58%	3091.96%
Free Cash Flow	-	-183.43	6.96	7.82	4.54	18.85
Free Cash Flow Per Share	-	-1.45	0.07	0.07	0.04	0.18
Gross Margin	11.17%	13.44%	13.73%	21.48%	16.23%	14.14%
Operating Margin	-2.01%	-0.40%	0.73%	12.74%	8.48%	4.13%
Profit Margin	-0.45%	0.83%	0.83%	9.48%	5.31%	1.95%
Free Cash Flow Margin	-	-18.52%	0.81%	1.12%	0.60%	3.51%
EBITDA	-20.53	-1.53	8.86	91.37	66.8	24.48
EBITDA Margin	-1.80%	-0.15%	1.03%	13.11%	8.81%	4.55%
D&A For EBITDA	2.35	2.45	2.57	2.63	2.51	2.26
EBIT	-22.88	-3.97	6.3	88.74	64.29	22.21
EBIT Margin	-2.00%	-0.40%	0.73%	12.74%	8.48%	4.13%
Effective Tax Rate	-	33.32%	22.37%	25.35%	29.76%	25.51%
Revenue as Reported	1,177	1,022	883.13	718.92	776.09	555.83
Advertising Expenses	-	4.48	4.86	5.29	0.86	0.66

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.